
| (Exact name of registrant as specified in its charter) | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | ||
( | ||
| (Registrant’s telephone number, including area code) | ||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) Exhibits. | |||||
| Exhibit No. | Description | ||||||||||
| 99.1 | |||||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||||||||
| MICRON TECHNOLOGY, INC. | |||||||||||
| Date: | By: | /s/ David A. Zinsner | |||||||||
| Name: | David A. Zinsner | ||||||||||
| Title: | Senior Vice President and Chief Financial Officer | ||||||||||
| Contacts: | Farhan Ahmad | Erica Rodriguez Pompen | ||||||
| Investor Relations | Media Relations | |||||||
| [email protected] | [email protected] | |||||||
| (408) 834-1927 | (408) 834-1873 | |||||||
| Quarterly Financial Results | |||||||||||||||||||||||
| (in millions, except per share amounts) | GAAP(1) | Non-GAAP(2) | |||||||||||||||||||||
| FQ1-21 | FQ4-20 | FQ1-20 | FQ1-21 | FQ4-20 | FQ1-20 | ||||||||||||||||||
| Revenue | $ | 5,773 | $ | 6,056 | $ | 5,144 | $ | 5,773 | $ | 6,056 | $ | 5,144 | |||||||||||
| Gross margin | 1,736 | 2,068 | 1,366 | 1,784 | 2,111 | 1,405 | |||||||||||||||||
| percent of revenue | 30.1 | % | 34.1 | % | 26.6 | % | 30.9 | % | 34.9 | % | 27.3 | % | |||||||||||
| Operating expenses | 870 | 911 | 848 | 811 | 809 | 811 | |||||||||||||||||
| Operating income | 866 | 1,157 | 518 | 973 | 1,302 | 594 | |||||||||||||||||
| percent of revenue | 15.0 | % | 19.1 | % | 10.1 | % | 16.9 | % | 21.5 | % | 11.5 | % | |||||||||||
| Net income attributable to Micron | 803 | 988 | 491 | 897 | 1,229 | 548 | |||||||||||||||||
| Diluted earnings per share | 0.71 | 0.87 | 0.43 | 0.78 | 1.08 | 0.48 | |||||||||||||||||
| FQ2-21 | GAAP(1) Outlook | Non-GAAP(2) Outlook | ||||||
Revenue | $5.8 billion ± $200 million | $5.8 billion ± $200 million | ||||||
Gross margin | 25% ± 1% | 31% ± 1% | ||||||
Operating expenses | $882 million ± $25 million | $825 million ± $25 million | ||||||
Interest (income) expense, net | $37 million | $35 million | ||||||
Diluted earnings per share | $0.41 ± $0.07 | $0.75 ± $0.07 | ||||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| December 3, 2020 | September 3, 2020 | November 28, 2019 | |||||||||
| Revenue | $ | 5,773 | $ | 6,056 | $ | 5,144 | |||||
| Cost of goods sold | 4,037 | 3,988 | 3,778 | ||||||||
| Gross margin | 1,736 | 2,068 | 1,366 | ||||||||
| Research and development | 647 | 630 | 640 | ||||||||
| Selling, general, and administrative | 214 | 231 | 211 | ||||||||
| Other operating (income) expense, net | 9 | 50 | (3) | ||||||||
| Operating income | 866 | 1,157 | 518 | ||||||||
| Interest income | 10 | 13 | 44 | ||||||||
| Interest expense | (48) | (50) | (47) | ||||||||
| Other non-operating income (expense), net | 13 | 5 | 46 | ||||||||
| 841 | 1,125 | 561 | |||||||||
| Income tax (provision) benefit | (51) | (136) | (55) | ||||||||
| Equity in net income (loss) of equity method investees | 13 | 1 | 2 | ||||||||
| Net income | 803 | 990 | 508 | ||||||||
| Net income attributable to noncontrolling interests | — | (2) | (17) | ||||||||
| Net income attributable to Micron | $ | 803 | $ | 988 | $ | 491 | |||||
| Earnings per share | |||||||||||
| Basic | $ | 0.72 | $ | 0.89 | $ | 0.44 | |||||
| Diluted | 0.71 | 0.87 | 0.43 | ||||||||
| Number of shares used in per share calculations | |||||||||||
| Basic | 1,115 | 1,111 | 1,107 | ||||||||
| Diluted | 1,135 | 1,131 | 1,129 | ||||||||
| As of | December 3, 2020 | September 3, 2020 | ||||||
| Assets | ||||||||
| Cash and equivalents | $ | 5,985 | $ | 7,624 | ||||
| Short-term investments | 1,047 | 518 | ||||||
| Receivables | 3,691 | 3,912 | ||||||
| Inventories | 5,521 | 5,607 | ||||||
| Other current assets | 285 | 304 | ||||||
| Total current assets | 16,529 | 17,965 | ||||||
| Long-term marketable investments | 1,264 | 1,048 | ||||||
| Property, plant, and equipment | 32,229 | 31,031 | ||||||
| Operating lease right-of-use assets | 577 | 584 | ||||||
| Intangible assets | 336 | 334 | ||||||
| Deferred tax assets | 726 | 707 | ||||||
| Goodwill | 1,228 | 1,228 | ||||||
| Other noncurrent assets | 802 | 781 | ||||||
| Total assets | $ | 53,691 | $ | 53,678 | ||||
| Liabilities and equity | ||||||||
| Accounts payable and accrued expenses | $ | 4,856 | $ | 5,817 | ||||
| Current debt | 273 | 270 | ||||||
| Other current liabilities | 559 | 548 | ||||||
| Total current liabilities | 5,688 | 6,635 | ||||||
| Long-term debt | 6,356 | 6,373 | ||||||
| Noncurrent operating lease liabilities | 529 | 533 | ||||||
| Noncurrent unearned government incentives | 656 | 643 | ||||||
| Other noncurrent liabilities | 555 | 498 | ||||||
| Total liabilities | 13,784 | 14,682 | ||||||
| Commitments and contingencies | ||||||||
| Shareholders’ equity | ||||||||
| Common stock | 120 | 119 | ||||||
| Additional capital | 9,034 | 8,917 | ||||||
| Retained earnings | 34,138 | 33,384 | ||||||
| Treasury stock | (3,495) | (3,495) | ||||||
| Accumulated other comprehensive income (loss) | 110 | 71 | ||||||
| Total equity | 39,907 | 38,996 | ||||||
| Total liabilities and equity | $ | 53,691 | $ | 53,678 | ||||
| Three months ended | December 3, 2020 | November 28, 2019 | ||||||
| Cash flows from operating activities | ||||||||
| Net income | $ | 803 | $ | 508 | ||||
Adjustments to reconcile net income to net cash provided by operating activities | ||||||||
| Depreciation expense and amortization of intangible assets | 1,487 | 1,296 | ||||||
| Amortization of debt discount and other costs | 7 | 10 | ||||||
| Stock-based compensation | 92 | 72 | ||||||
| (Gain) loss on debt prepayments, repurchases, and conversions | — | (42) | ||||||
Change in operating assets and liabilities | ||||||||
| Receivables | 251 | (208) | ||||||
| Inventories | 86 | 175 | ||||||
| Accounts payable and accrued expenses | (753) | 178 | ||||||
| Deferred income taxes, net | (24) | 19 | ||||||
| Other | 18 | 3 | ||||||
| Net cash provided by operating activities | 1,967 | 2,011 | ||||||
| Cash flows from investing activities | ||||||||
| Expenditures for property, plant, and equipment | (2,738) | (1,943) | ||||||
| Purchases of available-for-sale securities | (1,002) | (407) | ||||||
| Proceeds from maturities of available-for-sale securities | 216 | 163 | ||||||
| Proceeds from sales of available-for-sale securities | 45 | 988 | ||||||
| Proceeds from government incentives | 40 | 22 | ||||||
| Other | 21 | (12) | ||||||
| Net cash provided by (used for) investing activities | (3,418) | (1,189) | ||||||
| Cash flows from financing activities | ||||||||
| Payments on equipment purchase contracts | (97) | (11) | ||||||
| Repayments of debt | (84) | (1,415) | ||||||
| Acquisition of noncontrolling interest in IMFT | — | (744) | ||||||
| Proceeds from issuance of debt | — | 1,250 | ||||||
| Other | (33) | (72) | ||||||
| Net cash provided by (used for) financing activities | (214) | (992) | ||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash | 27 | (14) | ||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | (1,638) | (184) | ||||||
| Cash, cash equivalents, and restricted cash at beginning of period | 7,690 | 7,279 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 6,052 | $ | 7,095 | ||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| December 3, 2020 | September 3, 2020 | November 28, 2019 | |||||||||
| GAAP gross margin | $ | 1,736 | $ | 2,068 | $ | 1,366 | |||||
| Stock-based compensation | 41 | 37 | 31 | ||||||||
| Other | 7 | 6 | 8 | ||||||||
| Non-GAAP gross margin | $ | 1,784 | $ | 2,111 | $ | 1,405 | |||||
| GAAP operating expenses | $ | 870 | $ | 911 | $ | 848 | |||||
| Stock-based compensation | (51) | (52) | (41) | ||||||||
| Restructure and asset impairments | (8) | (50) | 4 | ||||||||
| Non-GAAP operating expenses | $ | 811 | $ | 809 | $ | 811 | |||||
| GAAP operating income | $ | 866 | $ | 1,157 | $ | 518 | |||||
| Stock-based compensation | 92 | 89 | 72 | ||||||||
| Restructure and asset impairments | 8 | 50 | (4) | ||||||||
| Other | 7 | 6 | 8 | ||||||||
| Non-GAAP operating income | $ | 973 | $ | 1,302 | $ | 594 | |||||
GAAP net income attributable to Micron | $ | 803 | $ | 988 | $ | 491 | |||||
| Stock-based compensation | 92 | 89 | 72 | ||||||||
| Restructure and asset impairments | 8 | 50 | (4) | ||||||||
| Amortization of debt discount and other costs | 7 | 6 | 10 | ||||||||
| (Gain) loss on debt prepayments, repurchases, and conversions | — | — | (42) | ||||||||
| Other | 7 | 6 | 8 | ||||||||
Estimated tax effects of above and non-cash changes in net deferred income taxes | (20) | 90 | 13 | ||||||||
| Non-GAAP net income attributable to Micron | $ | 897 | $ | 1,229 | $ | 548 | |||||
GAAP weighted-average common shares outstanding - Diluted | 1,135 | 1,131 | 1,129 | ||||||||
Adjustment for stock-based compensation and capped calls | 11 | 11 | 9 | ||||||||
Non-GAAP weighted-average common shares outstanding - Diluted | 1,146 | 1,142 | 1,138 | ||||||||
GAAP diluted earnings per share | $ | 0.71 | $ | 0.87 | $ | 0.43 | |||||
Effects of the above adjustments | 0.07 | 0.21 | 0.05 | ||||||||
Non-GAAP diluted earnings per share | $ | 0.78 | $ | 1.08 | $ | 0.48 | |||||
| 1st Qtr. | 4th Qtr. | 1st Qtr. | |||||||||
| December 3, 2020 | September 3, 2020 | November 28, 2019 | |||||||||
GAAP net cash provided by operating activities | $ | 1,967 | $ | 2,271 | $ | 2,011 | |||||
| Investments in capital expenditures, net | |||||||||||
Expenditures for property, plant, and equipment, net(1) | (2,726) | (2,268) | (1,936) | ||||||||
Payments on equipment purchase contracts | (97) | (14) | (11) | ||||||||
Amounts funded by partners | 40 | 122 | 22 | ||||||||
Adjusted free cash flow | $ | (816) | $ | 111 | $ | 86 | |||||
| As of | December 3, 2020 | September 3, 2020 | ||||||
Cash and short-term investments | $ | 7,032 | $ | 8,142 | ||||
Current and noncurrent restricted cash | 67 | 66 | ||||||
Long-term marketable investments | 1,264 | 1,048 | ||||||
Current and long-term debt | (6,629) | (6,643) | ||||||
Net cash | $ | 1,734 | $ | 2,613 | ||||
| GAAP Outlook | Adjustments | Non-GAAP Outlook | |||||||||||||||||||||
Revenue | $5.8 billion ± $200 million | — | $5.8 billion ± $200 million | ||||||||||||||||||||
Gross margin | 25% ± 1% | 6% | A | 31% ± 1% | |||||||||||||||||||
Operating expenses | $882 million ± $25 million | $57 million | B | $825 million ± $25 million | |||||||||||||||||||
| Interest (income) expense, net | $37 million | $2 million | C | $35 million | |||||||||||||||||||
Diluted earnings per share(1) | $0.41 ± $0.07 | $0.34 | A, B, C, D | $0.75 ± $0.07 | |||||||||||||||||||
Non-GAAP Adjustments (in millions) | |||||||||||||||||||||||
A | Inventory accounting policy change to FIFO – cost of goods sold | $ | 135 | ||||||||||||||||||||
A | Change in inventory cost absorption – cost of goods sold | 165 | |||||||||||||||||||||
A | Stock-based compensation – cost of goods sold | 54 | |||||||||||||||||||||
A | Other – cost of goods sold | 7 | |||||||||||||||||||||
B | Stock-based compensation – research and development | 30 | |||||||||||||||||||||
B | Stock-based compensation – sales, general, and administrative | 27 | |||||||||||||||||||||
C | Amortization of debt discount and other costs | 2 | |||||||||||||||||||||
D | Tax effects of the above items and non-cash changes in net deferred income taxes | (27) | |||||||||||||||||||||
| $ | 393 | ||||||||||||||||||||||